THE USE OF SERUM AMINOTERMINAL PROPETIDE OF TYPE III PROCOLLAGEN (PSHINP) CONCENTRATION IN PREDICTING THE RESPONSE TO GROWTH HORMONE (GH) THERAPY IN SHORT CHILDREN
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.